The RAPS learning platform provider will be upgrading its security posture. This will take the system off-line from 20 July through the end of the day 23 July. This will affect any Online Course, eBook, and Virtual Program Attendance. Thank you for your patience.
'We Are All in This Together:' Regulatory Professionals and the Future of Personalized Medicine
Posted 01 March 2011 | By
In her February 2010 speech to the Personalized Medicine Coalition, US Food and Drug Administration (FDA) Commissioner Margaret Hamburg set forward a prospective view of the regulatory conditions necessary to support the advancement of personalized medicine. "[W]e need to develop a consistent, comprehensive and integrated approach to the evaluation and regulation of medical products which separately, and in combination, comprise the practice of personalized medicine." After expounding upon the changes the current system must undergo to move toward this new approach, the commissioner issued this admonition: "I want to underscore the point that we are all in this together."1